Description: Medtronic Inc. is a global medical device manufacturer has leadership positions in the pacemaker, defibrillator, orthopedic , diabetes management and other medical markets. Fair Value: In calculating fair value, I consider the NPV MMA Differential
Zimmer Holdings (NYSE: ZMH ) will hear back from EU antitrust authorities by Oct. 3 ..... to pursue its $13.4B takeover of rival Biomet (Pending: BMET ). Zimmer originally sought approval in June, but the EU regulator paused the review
BRUSSELS, Sept 1 (Reuters) - European Union antitrust regulators will decide by Oct. 3 whether to give the green light to U.S. orthopaedic products maker Zimmer Holdings ' $13.4 billion takeover of...
Johnson & Johnson's ( JNJ -0.3% ) DePuy Synthes unit recalls certain lots of its Craniomaxillofacial Distraction System also called External Mandibular Fixator and/or Distractor and a Bone Plate. The lots are being recalled due to the risk of the device reversing direction and losing the desired ...
Zimmer Holdings (NYSE: ZMH ) declares $0.22/share quarterly dividend , in line with previous. Forward yield 0.88% Payable Oct. 31; for shareholders of record Sept. 26; ex-div Sept. 24. Post your comment!
product. The most advanced of Mesoblast's clinical trial programs are targeting cardiovascular, bone marrow replacement and orthopedic diseases. Mesoblast is also targeting other disease areas such as diabetes, Alzheimer's and macular degeneration. Valuation
have less influence on brand decisions compared with highly engineered, implantable devices. Unlike St. Jude Medical and Zimmer 's devices, Bard's products are generally more vulnerable to pricing pressure. However, Bard's products are also typically
Aug 22 (Reuters) - Episurf Medical AB : * Says signed an agreement with the orthopedic specialist clinic Sportsmedicine Umeå * Source text for Eikon * Further company coverage
which makes regenerative medical biological materials and orthopedic implant products. In November 2013, PW Medtech staged a ..... Hong Kong. PW Medtech's existing business is centered on orthopedic implants and infusion equipment. Walvax Biotechnology (SHE
Aug 4 (Reuters) - Symmetry Medical Inc said it would sell its orthopedic device component business to privately held Tecomet Inc for $450 million.